research-article
Efficient Production of Mice from Embryonic Stem Cells Injected into Four- or Eight-Cell Embryos by Piezo Micromanipulation
Article first published online: 8 MAY 2008
DOI: 10.1634/stemcells.2008-0164
Copyright © 2008 AlphaMed Press
Additional Information
How to Cite
Huang, J., Deng, K., Wu, H., Liu, Z., Chen, Z., Cao, S., Zhou, L., Ye, X., Keefe, D. L. and Liu, L. (2008), Efficient Production of Mice from Embryonic Stem Cells Injected into Four- or Eight-Cell Embryos by Piezo Micromanipulation. STEM CELLS, 26: 1883–1890. doi: 10.1634/stemcells.2008-0164
Publication History
- Issue published online: 2 JAN 2009
- Article first published online: 8 MAY 2008
- Manuscript Accepted: 28 APR 2008
- Manuscript Received: 19 FEB 2008
- Abstract
- Article
- References
- Cited By
Keywords:
- Embryonic stem cells;
- Piezo microinjection;
- Mice;
- Pluripotency
Abstract
The conventional method for producing embryonic stem (ES) cell-derived knockout or transgenic mice involves injection of ES cells into normal, diploid blastocysts followed by several rounds of breeding of resultant chimeras and thus is a time-consuming and inefficient procedure. F0 ES cell pups can also be derived directly from tetraploid embryo complementation, which requires fusion of two-cell embryos. Recently, F0 ES cell pups have been produced by injection of ES cells into eight-cell embryos using a laser-assisted micromanipulation system. We report a simple method for producing F0 ES cell germline-competent mice by piezo injection of ES cells into four- or eight-cell embryos. The efficiency of producing live, transgenic mice by this method is higher than that with the tetraploid blastocyst complementation method. This efficient and economical technique for directly producing F0 ES cell offspring can be applicable in many laboratories for creating genetically manipulated mice using ES cell technology and also for stringent testing of the developmental potency of new ES cell or other types of pluripotent stem cell lines.
Disclosure of potential conflicts of interest is found at the end of this article.

1549-4918/asset/olbannerleft.jpg?v=1&s=699114e871887e6b838f6a1c657fe256cfe127a6)
1549-4918/asset/olbannerright.gif?v=1&s=603f8f2ab5cd9d4f783c231915608956af51aeea)
1549-4918/asset/cover.gif?v=1&s=51ac62b4272cd760b70f0cb1539035cc40743da6)